Literature DB >> 3811611

[Elimination of measles, mumps and rubella in Switzerland].

C Herzog.   

Abstract

The combined measles, mumps and rubella live vaccine nowadays available is very well tolerated and confers lifelong immunity. A complete immunization coverage among toddlers, schoolchildren and adolescents should nearly eliminate these three childhood diseases in a given population. The cost/benefit ratio of the immunization is for all three diseases rewarding in Switzerland. Reactions expected to the combined vaccine are mild and complications negligible in comparison to the diseases prevented. Starting in 1987 a nationwide campaign will begin in Switzerland; the aim is to vaccinate next to toddlers all so far non-vaccinated 6-7 years old and 14-15 years old schoolchildren respectively for a period of 8 years.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3811611     DOI: 10.1007/bf02077510

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  9 in total

1.  [Are measles and mumps vaccinations worth while in Switzerland?].

Authors:  M Just
Journal:  Schweiz Med Wochenschr       Date:  1978-11-11

2.  Measles--United States, 1985.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-06-06       Impact factor: 17.586

3.  [New Swiss vaccination schedule].

Authors:  M Just
Journal:  Ther Umsch       Date:  1986-07

4.  [Elimination of measles in Europe].

Authors:  S Suter
Journal:  Ther Umsch       Date:  1986-07

5.  Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.

Authors:  H Peltola; V Karanko; T Kurki; V Hukkanen; M Virtanen; K Penttinen; M Nissinen; O P Heinonen
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321

6.  Adult immunization. Recommendations of the Immunization Practices Advisory Committee. (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1984-09-28       Impact factor: 17.586

7.  Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children.

Authors:  T Vesikari; E L Ala-Laurila; A Heikkinen; A Terho; E D'Hondt; F E André
Journal:  Am J Dis Child       Date:  1984-09

Review 8.  Indications and contraindications for vaccines used in the Expanded Programme on Immunization.

Authors:  A M Galazka; B A Lauer; R H Henderson; J Keja
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

9.  Benefits, risks and costs of immunization for measles, mumps and rubella.

Authors:  C C White; J P Koplan; W A Orenstein
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

  9 in total
  2 in total

1.  Niche differentiation is spatially and temporally regulated in the rhizosphere.

Authors:  Erin E Nuccio; Evan Starr; Ulas Karaoz; Eoin L Brodie; Jizhong Zhou; Susannah G Tringe; Rex R Malmstrom; Tanja Woyke; Jillian F Banfield; Mary K Firestone; Jennifer Pett-Ridge
Journal:  ISME J       Date:  2020-01-17       Impact factor: 10.302

2.  Context-dependent dynamics lead to the assembly of functionally distinct microbial communities.

Authors:  Leonora S Bittleston; Matti Gralka; Gabriel E Leventhal; Itzhak Mizrahi; Otto X Cordero
Journal:  Nat Commun       Date:  2020-03-18       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.